Author

D. Shu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Huang· 1 shared B. Ju· 1 shared B. Zhou· 1 shared C. Li· 1 shared C.-N. Qian· 1 shared D. Xie· 1 shared F. Luo· 1 shared H. Guo· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. Huang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2

C. Li, H. Zhou, L. Guo, D. Xie, H. He, H. Zhang, Y. Liu, L. Peng, L. Zheng, W. Lu, Y. Mei, Z. Liu, J. Huang, M. Wang, D. Shu, , C.-N. Qian

This paper identifies TS-984 as a potent inhibitor of the SARS-CoV-2 spike protein-ACE2 interaction through a high-throughput screening platform and in vitro validation.

bioRxiv · Dec 14, 2021Pharmacology & Toxicology

Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine

B. Ju, B. Zhou, S. Song, Q. Fan, X. Ge, H. Wang, L. Cheng, H. Guo, D. Shu, L. Liu, Z. Zhang

A third dose of inactivated SARS-CoV-2 vaccine significantly enhances plasma neutralization and generates high-affinity anti-RBD memory B cells against variants like Beta, Delta, and Lambda.

bioRxiv · Nov 10, 2021Immunology